Skip to main content
Fig. 7 | Experimental Hematology & Oncology

Fig. 7

From: Identification of potential resistance mechanisms and therapeutic targets for the relapse of BCMA CAR-T therapy in relapsed/refractory multiple myeloma through single-cell sequencing

Fig. 7

The difference of signaling pathways between baseline and progression in R/R-MM. A The number of inferred interactions between baseline and progression in R/R-MM. B The interaction strength between baseline and progression in R/R-MM. C The number of inferred interactions for each group. D The overall information flow of each signaling pathway between baseline and progression in R/R-MM. E The outgoing signaling of each cell population between baseline and progression in R/R-MM. F The incoming signaling of each cell population between baseline and progression in R/R-MM

Back to article page

Experimental Hematology & Oncology

ISSN: 2162-3619

Contact us